Shattuck Labs (STTK) News
NASDAQ: STTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.46-0.09 (-1.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
STTK news summary
We found 2 recent headlines mentioning Shattuck Labs (STTK): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire. For price context, STTK is down 1.98% at $4.46. The most recent story, "Shattuck Labs GAAP EPS of -$0.14 misses by $0.04", was published by Seeking Alpha on Nov 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Shattuck Labs headlines
- Shattuck Labs GAAP EPS of -$0.14 misses by $0.04Seeking Alpha
- Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights– Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in Crohn’s disease; 12-week induction data expected in the first half of 2028 –GlobeNewswire